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Abstract 
Purpose: The aim of this research work was to formulate, characterize and evaluate the in vitro 
permeation behavior of tramadol lotion containing propylene glycol (PG) and polyethylene glycol (PEG) 
as permeation enhancers. 
Methods: The permeation experiments were conducted in vitro using full thickness rabbit skin in Franz 
diffusion cells. The donor compartment was filled with PBS (phosphate buffered saline) at pH 7.4 ± 0.1. 
The receptor phase was continuously stirred PBS (pH 7.4) at 37 °C ± 0.5. The amount of tramadol 
permeated into the receptor phase was determined spectrophotometrically at 271 nm. Various 
permeation parameters such as permeation coefficient (Kp), diffusion coefficient (D), flux (J), input rate, 
and enhancement ratio were obtained using Fick’s diffusion laws. 
Results: Permeation increased with increase in the concentrations of both enhancers tested. Maximum 
cumulative amount permeated for control lotion (Lc) was 357 µg/cm
2/min with input rate 0.574 µg/min 
and lag time (tlag) of 34.93 min, while for the optimum test lotion (L4, containing 8 % PG/PEG in ratio of 
1:1 v/v), it was 926 µg/cm2/min, 1.482 µg/min and 58.36 min, respectively. The significantly (p < 0.05) 
higher permeability shown by the test lotion L4 can be attributed, in part, to the interaction of PG with 
intercellular lipids leading to the disruption of their organization and increasing their fluidity, and also 
partly as a result of solubilization of lipid bilayers by PEG. 
Conclusion: A binary system of PG and PEG in lotion can be successfully utilized for the permeation 
enhancement of tramadol. 
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In a broad sense, the term TDDS (transdermal 
drug delivery system) includes all topically 
administered drug formulations intended to 
deliver the active ingredient into general 
circulation [1]. Ideally, the entire drug should 
penetrate through the skin to the underlying 
blood supply without any accumulation in the 
layers of the skin for successful transdermal 
delivery which often involves a demonstration of 
clinical safety and effectiveness.  
 
Although TDDS was introduced more than 200 
years ago [2], it is only recently that the method 
Shah et al 
Trop J Pharm Res, February 2013;12 (1): 
 
28 
appears to have reached a practical stage [3]. A 
closely related term is percutaneous delivery, 
which is the transport of drugs into target tissues 
with the aim to avoid systemic effects. The 
concept of percutaneous absorption of drugs was 
given by Stoughton in 1965 [4). TDDS provides 
various merits over conventional drug delivery 
systems such as oral and parenteral delivery, 
including avoidance of hepatic first pass 
metabolism, reduction of pain, and possible 
sustained release of drugs [5-7]. 
 
Chemical enhancers are substances which 
momentarily diminish skin obstacle and 
accelerate drug absorption. Enhancers include 
essential oils, terpenes, terpenoids, azone, 
pyrrolidones, fatty acids, sulphoxides, 
oxazolidinones and urea. Propylene glycol and 
polyethylene glycol can easily penetrate the skin 
and has assessed as a skin penetration 
enhancer in several in vitro studies [8]. 
 
Tramadol HCl (TRA) is a centrally acting opioid 
synthetic analgesic which acts through selective 
binding to the µ-opioid receptor as well as weak 
inhibition of norepinephrine and serotonin 
uptake. It is employed in severe acute or chronic 
pains. TRA is a basic drug with pKa = 9.3 [9,10]. 
To the best of our knowledge, no study has 
addressed in detail the formulation of tramadol 
as a lotion. The aim of this work, therefore, was 
to formulate, characterize and evaluate the in 
vitro permeation behavior of tramadol lotion 
containing propylene glycol (PG) and 







Tramadol hydrochloride (purity 99.7 %, TRA) 
was a gift by Ali Gohar Pharmaceuticals, 
Karachi, Pakistan. Propylene glycol (PG), 
isopropyl alcohol (IPA) and sodium chloride 
(NaCl) were purchased from Merck, Germany. 
Polyethylene glycol (PEG 1000), potassium 
dihydrogen phosphate and disodium hydrogen 
phosphate (Na2HPO4·12H2O) were procured 
from Fluka, Germany. Potassium chloride (KCl, 
Aldrich Chemical, USA), vacuum grease (Dow 
Corning, USA), carbomer-980 (Merck, Germany), 
sodium hydroxide (Shama Laboratory Chemical 
Works, Lahore) were purchased from local 
suppliers. All the chemicals used were of 
analytical grade and used without further 
treatment. Glass double-distilled water was used 
throughout the study. 
 
 
Preparation of hydro-alcoholic lotions 
 
Hydro-alcoholic lotions (L1 - L5, 100 ml each) of 
TRA having varying concentrations (2, 4, 6, 8 
and 10 %) of permeation enhancers (PG and 
PEG in a ratio of 1:1 v/v) were prepared in a 100 
ml volumetric flask. To prepare the lotions, TRA 
(50 mg) was dissolved in 10 ml of isopropyl 
alcohol in a 100 ml volumetric flask followed by 
the addition of carbomer-980 (1.5 mg) with 
continuous shaking. PG, PEG, and phosphate 
buffer (0.1 ml) were added and the volume made 
up to 100 ml with distilled water. Control 
formulation (Lc) which contained the same 
ingredients in the same amounts, except an 
enhancer, was also made. 
 
In vitro characterization studies 
 
Each TRA-containing lotion was tested to assess 
its physical properties including pH, viscosity, 
spreadability, homogenity and drug solubility. 
Each of these analyses was conducted in 
triplicate (n = 3). 
 
The pH of the lotions was tested using a digital 
pH meter (Mettler & Toledo, Giessen, Germany).  
The viscosity was determined using a Brookfield 
viscometer (Model RVTDV II, Stoughton, USA) at 
room temperature (25 ± 2 °C).  A C-50 spindle 
was used with a stirring speed of 220 rpm. The 
gap value was fixed at 0.3 mm. 
Lotion spreadability was tested by the wooden 
block and glass slide method as presented 
previously [11]. Briefly, 5 mL of the lotion was 
adjoined to a dedicated pan and the time taken 
for a movable upper slide to detach entirely from 
the fixed slides was observed. Spreadability (S) 
was evaluated asin Eq 1. 
     
S = M.L/t ……………………….. (1) 
 
where M = weight/volume tide to upper slide, L = 
length of glass slide and t = time taken to 
separate the slide completely from each other. 
Visual examination was used to evaluate the 
homogeneity of each lotion. To assess 
aggregation, the appearance of the lotions was 
observed [12]. 
 
Each TRA-containing lotion was tested for drug 
content. The lotion (5 mL) was dissolved in 
ethanol (5 mL) and PBS (pH 7.4) added to make 
up the final volume to 100 mL. The mixture was 
vigorously mixed for 2 h on a mechanical shaker, 
filtered and the supernatant layer then analyzed 
spectrophotometrically for TRA at 271 nm using 
UV/Vis spectrophotometer (model 1601, 
Shmadzu, Japan) [7]. 
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Accelerated stability studies of the formulated 
lotions were conducted at a temperature of 40 ± 
2 ºC, 75 %RH for 3 months.  Each lotion was 
tested for alterations in its appearance, pH, 
viscosity and drug content after 12 h, 1 day, 7 
days, 1 month and 3 months. Each of these 
analyses was conducted in triplicate (n = 3). 
 
In vitro permeation studies  
 
In vitro permeation studies of TRA lotions across 
rabbit skin were carried out using two-chambered 
Franz-type diffusion cells (manufactured “in 
house”) [6] having a receptor phase of ~5 ml, 
and a diffusional area of ~0.788 cm2. 
 
Following approval (approval No. 34-
2008/BZU.PHM) by the Board of Advance 
Studies and Research, Faculty of Pharmacy, 
Bahauddin Zakariya University, Multan, Pakistan, 
this study was conducted in accordance with the 
international guidelines for animal use in 
laboratory experimentation [13]. Adult rabbit skin 
was used for permeation studies at 37 ± 0.5 oC. 
Abdominal full thickness skin of male White New 
Zealand rabbit (3 - 4 kg weight) was carefully 
excised after sacrificing the rabbit. Subcutaneous 
fats and other extraneous tissues adhering to the 
dermis were completely removed and trimmed 
with forceps and scissor. The skin was cleaned 
with phosphate buffered saline (PBS) at pH 7.4 
and stored in 500 ml normal saline in a 
refrigerator (18 – 20 oC) [6,7].  
 
The skin was used within one week of excision. 
Sheets of the skin were cut to appropriate sizes 
(~ 1 cm2 in diameter) and soaked overnight in the 
receptor solution (PBS).  The membrane was 
then placed between the two compartments of 
the diffusion cells with epidermis side facing the 
donor compartment while the dermal side  was 
bathed with PBS at pH 7.4 (receptor fluid). The 
donor compartment was filled with PBS at pH 7.4 
± 0.1. This pH is close to that of human skin. The 
receptor fluid was stirred with a magnetic stirring 
bar at 500 rpm, keeping the temperature at 37 ± 
0.5 oC by means of a water jacket. Care was 
exercised to remove any bubbles between the 
underside of the skin and the solution in the 
receiver compartment. Vacuum grease was used 
to produce a leak-proof seal between the 
membrane and the two compartments of the 
diffusion cell, i.e., donor and receptor. 
 
The receptor and donor compartments were filled 
with PBS at pH 7.4 ± 0.1. To remove air bubbles 
and preclude the development of air pockets in 
the receptor phase, PBS was degassed in an 
ultrasonic bath. To avoid evaporation from the 
compartments, the cell arm and donor 
compartment were covered with a parafilm. 
Constant mixing of the receptor phase was 
obtained with a magnetic stirrer placed in the 
receptor compartment. The diffusion cells were 
placed on a stirring-bed immersed in a water 
bath at 37 ± 0.05oC, to maintain the temperature 
of membrane surface. After 24 hours, both 
chambers were cleared of PBS and the receptor 
compartment was immediately refilled with pre-
thermostated PBS, while the skin remained 
intact. The donor compartment was charged with 
1 ml of the lotion (test formulation). At time 
intervals of 5, 15, 30, 60, 90, 120, 180, 240, 360 
and 480 min, 0.2 ml sample was drawn, using a 
micro-pipette, from receptor solution followed by 
addition of same volume of pre-thermostated 
receptor solution to maintain sink conditions. The 
samples were analyzed spectrophotometrically at 
271 nm using UV/Vis spectrophotometer (model 
1601, Shmadzu, Japan) to obtain the amount of 
TRA permeated through rabbit skin after diluting 
with 1.8 ml PBS. Since skin shows great sample-
to-sample permeability variations [12], each of 
these analyses was conducted in pentaplicate (n 
= 5). 
 
To construct a calibration curve, 500 mg of TRA 
was dissolved in PBS (10 ml) in 100 ml 
volumetric flask and the final volume made up to 
100 ml by adding PBS to prepare stock solution. 
From this solution, dilutions of 10, 20, 30, 40, 50, 
60, 70, and 80 µg/ml were prepared. The 
resultant dilutions were analyzed 
spectrophotometrically for UV absorbance’ 
maximum UV absorbance of TRA was found at 
271 nm [9,10]. The linear equation of the 
constructed calibration curve was y = 0.022x - 
0.021 and correlation coefficient (R2) of 0.998. 
Steady-state flux was determined from the slope 
of the linear portion of the cumulative amount of 
permeation (Q) versus time (t) plot. 
The input rate of TRA (Table 1) permeating 
across rabbit skin was determined as in Eq 2 
 
      Input rate = Kp × C × A …………….. (2) 
 
where, Kp is permeability coefficient, C is donor 
amount (µg), i.e., amount of drug in the donor 
compartment and A is the Franz cell area of 
permeation (~0.788 cm2). Enhancement ratio 
(ER) was calculated by dividing the flux of the 




The results are expressed as mean ± standard 
deviation (SD, n = 5). Statistically significant 
differences between various permeation data 
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were determined using F-test, Fisher’s least 
significant difference (LSD), analysis of variance 





Physicochemical characteristics of the 
tramadol lotions  
 
All TRA-containing lotions (L1 - L5) emerged as 
clear, colorless and homogenous solutions 
without any aggregates. The pH of all the lotions 
was ~7.9 and there was no significant difference 
(p > 0.05) among all the formulations. There was, 
however, significant differences in their 
viscosities (p < 0.05), viz, (54.00 ± 0.93) ×10-3, 
(57.00 ± 0.86) × 10-3, (64.00 ± 1.12) ×10-3, (71.00 
± 1.33) ×10-3 and (97.00 ± 1.19) × 10-3 g cm-1 s-1 
for L1, L2, L3, L4 and L5, respectively. 
Spreadability also varied significantly (p < 0.05), 
being 2.91 ± 0.11, 2.83 ± 0.08, 2.03 ± 0.02, 1.87 
± 0.04 and 1.10 ± 0.03 mg cm s -1, respectively. It 
is evident from these values that spreadability of 
lotion decreased with the increase in PG-PEG 
content. 
 
Based on visual observation, no formulation 
showed any alteration in appearance, 
opaqueness or color at the end of the 
accelerated stability studies. There was also no 
significant difference (p > 0.05) in pH, viscosity, 
spreadability, drug content or permeation through 
rabbit skin at the end of the accelerated stability 
studies. 
 
In vitro permeation 
 
The cumulative amount permeated of TRA 
through rabbit skin using different hydro-alcoholic 
lotions is presented in Figure 1. The input rate of 
tramadol is shown in Table 1. The various 
permeation parameters calculated for the lotions 
are shown in Table 2. Drug permeation data 
(through full thickness rabbit skin) are given in 
Figure 1. A significant difference between the 
cumulative amount (µg/cm2) of TRA permeated 
through rabbit skin in the presence of PG and 
PEG as permeation enhancers was found when 
F-Test, Fisher’s least significant difference 
(LSD), and multiple range tests were employed, 
but the multiple range test did not show a 
significant difference between L4 and L5 (p > 
0.05). This is also supported by the calculated 
enhancement ratio data shown in Table 2. 
 
The data presented here show that PG and PEG 
have synergistic effects on the delivery of TRA 
across the skin. The results also indicate that 
permeation of TRA increased with increase in the 
concentration of PG and PEG; maximum 
cumulative amount of TRA permeated through 
rabbit skin was obtained with L4 (Figure 1). L1, L2 
and L3 showed largely the same permeation 
enhancement effects. 
 
Table 1:  Input rate (µg/cm2.min) of TRA from hydro-
alcoholic lotions 
 











The stratum corneum (SC) of mammalian skin is 
considered to be a permeation barrier for water 
and most solutes whereas the intercellular lipid 
multilayer domains of SC are believed to present 
a diffusional pathway for most lipophilic solutes. 
Permeation enhancers (PG and PEG) enter the 
SC and change the solution properties of SC by 
altering the chemical environment and thus 
dissolve the barrier capacity of this cutaneous 
layer [7].  
 
The apparent effects of the enhancers (PG and 
PEG) used in the present study may be 
dependent on their concentrations as evident  
 
 




















Lc 34.94 0.045 0.001457 0.73 0.57 - 
L1 38.43 0.049 0.001637 0.82 0.65 1.12 
L2 47.27 0.061 0.001771 0.89 0.69 1.21 
L3 73.86 0.095 0.001871 0.94 0.74 1.28 
L4 58.37 0.075 0.003762 1.88 1.48 2.58 
L5 64.56 0.083 0.002542 1.27 1.00 1.74 
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   Table 3:   Multiple range tests: 95.0 % LSD 
 
Formulation Count Mean Homogeneous groups 
LC 10 140.742 X 
L1 10 160.892 X 
L2 10 181.845 X 
L3 10 217.081 X 
L5 10 282.993 XX 
L4 10 407.094 X 
Multiple range tests 
Contrast Sig. Difference +/- Limits 
L1 - L2  -20.9523 167.148 
L1 - L3  -56.188 167.148 
L1 - L4 * -246.202 167.148 
L1 - L5  -122.101 167.148 
L1 – LC  20.1501 167.148 
L2 - L3  -35.2357 167.148 
L2 - L4 * -225.25 167.148 
L2 - L5  -101.148 167.148 
L2 – LC  41.1024 167.148 
L3 - L4 * -190.014 167.148 
L3 - L5  -65.9126 167.148 
L3 - LC  76.3381 167.148 
L4 - L5  124.101 167.148 
L4 - LC * 266.352 167.148 
L5 - LC  142.251 167.148 
                       





Figure 1: Permeation profile of tramadol from various 
hydro-alcoholic lotions through rabbit skin; mean ± SD 
(n = 5) (-▲- Lc, -∆- L1, -♦- L2, -◊- L3, -□- L4, -■- L5) 
 
from results obtained. Permeation rate through 
rabbit skin followed Fick’s diffusion law and was 
mainly affected by the amount of PG and PEG-
1000 [14]. The increase in permeation with 
increase in enhancer content (except for L5) is 
expected based on the effect of the effect of 
enhancers on the skin which was mentioned 
above. The different behavior of L5 may be due 
to very high levels of enhancers leading possibly 
to retention of drug in the skin [15] as indicated in 
Table 2. 
 
PG also increases drug partitioning and drug 
permeation [16] and in combination with PEG 
and other enhancers, PG may increase drug flux 
possibly due to occupation of its hydrogen 
bonding sites as well as salvation of the keratin 
of stratum corneum. It has been suggested that 
the mechanism of skin permeation enhancement 
by PG occurs through the extraction of lipids 
from the SC layers [6,7,16]. 
PEG due to its solublizing properties is 
considered a good skin permeation enhancer, 
and when other lipophilic and hydrophilic 
surfactants are incorporated with it in 
formulations, enhances solubility and reduces 
hepatic metabolism by forming chylomicrons that 
uncrease lymphatic delivery, resulting in 
increased bioavailability [17]. This is buttressed 
by drug flux value of 1.271 µg/cm2/min for L5 
which is lower than that of L4 due to greater 
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solubliztion of the drug in the presence of high 
levels of PEG [18]. 
 
The increased permeability shown by L4 can be 
attributed, in part, to the interaction of PG with 
intercellular lipids, leading to disruption of their 
structural organization and increase in their 
fluidity and partial solubilization of the lipiophilic 
matrix by PEG. While K values are in order of L4 
> L1 > L5 > L2 > L3 and D values of the lotion are 
in order of L3 > L5 > L4 > L2 > L1, thus indicating 
that increase in PG and PEG-1000 levels also 





The data presented in this work suggest that 
formulation of an effective TDDS for the delivery 
of tramadol hydrochloride (TRA) is feasible. 
Improvement in the solubility and diffusivity of 
TRA is necessary to realize clinically effective 
transdermal delivery of the drug. Among the 
various combinations of PG and PEG examined 
in this study, formulation L4 (containing 8 % 
PG/PEG 1000 in a 1:1 ratio) yielded the most 
promising TDDS. Further work would, however, 
be required to achieve clinical levels in 
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